Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
9
YQ Quote, Financials, Valuation and Earnings
Last price:
$1.61
Seasonality move
:
38.01%
Day range:
$1.56 - $1.63
52-week range:
$1.48 - $3.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.46x
P/B ratio:
0.22x
Volume:
13.4K
Avg. volume:
31.1K
1-year change:
-0.94%
Market cap:
$12.5M
Revenue:
$24.2M
EPS (TTM):
-$3.76
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $58.8M | $187.6M | $338.3M | $79.1M | $24.2M | |
| Revenue Growth (YoY) | 25.13% | 218.91% | 80.39% | -76.63% | -69.43% | |
| Cost of Revenues | $25.1M | $71.8M | $136M | $30.7M | $12.8M | |
| Gross Profit | $33.7M | $115.7M | $202.3M | $48.4M | $11.4M | |
| Gross Profit Margin | 57.3% | 61.71% | 59.8% | 61.17% | 47.21% | |
| R&D Expenses | $71.1M | $89.1M | $123.9M | $35.1M | $23.7M | |
| Selling, General & Admin | $107.4M | $220M | $287.8M | $44.7M | $36.1M | |
| Other Inc / (Exp) | $1.9M | -$1.6M | -$17.7M | $3.3M | $446.3K | |
| Operating Expenses | $178.5M | $309.1M | $411.7M | $79.8M | $59.9M | |
| Operating Income | -$144.8M | -$193.3M | -$209.4M | -$31.4M | -$48.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$139.5M | -$194.2M | -$223.3M | -$26.5M | -$44.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$139.5M | -$194.2M | -$223.3M | -$26.5M | -$44.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$139.5M | -$194.2M | -$223.3M | -$26.5M | -$44.1M | |
| Basic EPS (Cont. Ops) | -$24.11 | -$323.72 | -$22.61 | -$2.61 | -$4.81 | |
| Diluted EPS (Cont. Ops) | -$24.11 | -$323.72 | -$22.61 | -$2.61 | -$4.81 | |
| Weighted Average Basic Share | $9.4M | $1.9M | $9.9M | $10.1M | $9.2M | |
| Weighted Average Diluted Share | $9.4M | $1.9M | $9.9M | $10.1M | $9.2M | |
| EBITDA | -$136.2M | -$188M | -$199.4M | -$27.8M | -$46.2M | |
| EBIT | -$139.5M | -$193.7M | -$209.4M | -$31.4M | -$48.5M | |
| Revenue (Reported) | $58.8M | $187.6M | $338.3M | $79.1M | $24.2M | |
| Operating Income (Reported) | -$144.8M | -$193.3M | -$209.4M | -$31.4M | -$48.5M | |
| Operating Income (Adjusted) | -$139.5M | -$193.7M | -$209.4M | -$31.4M | -$48.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $44.4M | $76.7M | $18.2M | $6.2M | $8.3M | |
| Revenue Growth (YoY) | -- | 72.95% | -76.3% | -65.73% | 33.63% | |
| Cost of Revenues | $20.5M | $38.8M | $4.6M | $2.9M | $3.3M | |
| Gross Profit | $23.9M | $37.9M | $13.6M | $3.4M | $5.1M | |
| Gross Profit Margin | 53.79% | 49.39% | 74.54% | 54.08% | 60.94% | |
| R&D Expenses | $22.2M | $31.1M | $7.4M | $6.3M | $1.8M | |
| Selling, General & Admin | $84.4M | $79M | $10.2M | $7.9M | $6.3M | |
| Other Inc / (Exp) | -$1.3M | -$4.4M | $156.6K | -$51.3K | $57.1K | |
| Operating Expenses | $106.6M | $110.1M | $17.6M | $14.2M | $8.1M | |
| Operating Income | -$82.7M | -$72.2M | -$4M | -$10.9M | -$3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$83.9M | -$75.7M | -$3.4M | -$10.1M | -$2.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$83.9M | -$75.7M | -$3.4M | -$10.1M | -$2.4M | |
| Basic EPS (Cont. Ops) | -$8.94 | -$7.64 | -$0.36 | -$1.17 | -$0.28 | |
| Diluted EPS (Cont. Ops) | -$8.94 | -$7.64 | -$0.36 | -$1.17 | -$0.28 | |
| Weighted Average Basic Share | $9.4M | $9.9M | $10M | $8.7M | $7.8M | |
| Weighted Average Diluted Share | $9.4M | $9.9M | $10M | $8.7M | $7.8M | |
| EBITDA | -$83.9M | -$72.2M | -$4M | -$10.9M | -$3M | |
| EBIT | -$83.9M | -$72.2M | -$4M | -$10.9M | -$3M | |
| Revenue (Reported) | $44.4M | $76.7M | $18.2M | $6.2M | $8.3M | |
| Operating Income (Reported) | -$82.7M | -$72.2M | -$4M | -$10.9M | -$3M | |
| Operating Income (Adjusted) | -$83.9M | -$72.2M | -$4M | -$10.9M | -$3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $142.7M | $327.1M | $159.9M | $23M | $27.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $56.2M | $132.3M | $58.6M | $11.7M | $17.1M | |
| Gross Profit | $86.5M | $194.8M | $101.3M | $11.4M | $10.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $78.7M | $127.9M | $53.1M | $25.3M | $13.4M | |
| Selling, General & Admin | $173M | $331M | $61.2M | $37.3M | $31.8M | |
| Other Inc / (Exp) | -$1.1M | -$13.2M | -$3.8M | $2.5M | $31.4K | |
| Operating Expenses | $251.7M | $458.9M | $114.3M | $62.6M | $45.2M | |
| Operating Income | -$165.1M | -$264.2M | -$13M | -$51.2M | -$34.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$165.2M | -$273.7M | -$15.3M | -$44.9M | -$31.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$165.2M | -$273.7M | -$15.3M | -$44.9M | -$31.7M | |
| Basic EPS (Cont. Ops) | -$28.59 | -$12.43 | -$1.53 | -$4.75 | -$3.76 | |
| Diluted EPS (Cont. Ops) | -$28.59 | -$28.26 | -$1.53 | -$4.75 | -$3.76 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$163.9M | -$262.7M | -$13M | -$51.2M | -$34.4M | |
| EBIT | -$164.8M | -$264.5M | -$13M | -$51.2M | -$34.4M | |
| Revenue (Reported) | $142.7M | $327.1M | $159.9M | $23M | $27.9M | |
| Operating Income (Reported) | -$165.1M | -$264.2M | -$13M | -$51.2M | -$34.4M | |
| Operating Income (Adjusted) | -$164.8M | -$264.5M | -$13M | -$51.2M | -$34.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $115.4M | $253.6M | $75.1M | $17.5M | $21.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $46.1M | $106.1M | $28.7M | $9M | $13.3M | |
| Gross Profit | $69.4M | $147.5M | $46.4M | $8.5M | $7.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $60.4M | $98.9M | $28.2M | $18.1M | $7.7M | |
| Selling, General & Admin | $148.3M | $258M | $32M | $24.7M | $20.5M | |
| Other Inc / (Exp) | -$953.1K | -$12.5M | $1.4M | $748K | $307.1K | |
| Operating Expenses | $208.7M | $356.9M | $60.2M | $42.8M | $28.1M | |
| Operating Income | -$139.4M | -$209.4M | -$13.8M | -$34.3M | -$20.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$139.9M | -$218.6M | -$11.3M | -$30.4M | -$18M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$139.9M | -$218.6M | -$11.3M | -$30.4M | -$18M | |
| Basic EPS (Cont. Ops) | -$23.53 | -$22.46 | -$1.14 | -$3.28 | -$2.23 | |
| Diluted EPS (Cont. Ops) | -$23.53 | -$22.46 | -$1.14 | -$3.28 | -$2.23 | |
| Weighted Average Basic Share | $28.2M | $29.2M | $30.4M | $28M | $23.3M | |
| Weighted Average Diluted Share | $28.2M | $29.2M | $30.4M | $28M | $23.3M | |
| EBITDA | -$139.5M | -$209.4M | -$13.8M | -$34.3M | -$20.2M | |
| EBIT | -$139.5M | -$209.4M | -$13.8M | -$34.3M | -$20.2M | |
| Revenue (Reported) | $115.4M | $253.6M | $75.1M | $17.5M | $21.3M | |
| Operating Income (Reported) | -$139.4M | -$209.4M | -$13.8M | -$34.3M | -$20.2M | |
| Operating Income (Adjusted) | -$139.5M | -$209.4M | -$13.8M | -$34.3M | -$20.2M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $93.5M | $433.9M | $185.3M | $102.6M | $43.3M | |
| Short Term Investments | -- | -- | -- | $2.8M | $23.9M | |
| Accounts Receivable, Net | -- | -- | -- | $5M | $8.4M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $7.4M | $29.9M | $21M | $17.2M | $12.7M | |
| Other Current Assets | $417.8K | $1.3M | $796.4K | $751.7K | $620K | |
| Total Current Assets | $108.3M | $466.3M | $210.7M | $132.4M | $89M | |
| Property Plant And Equipment | $20.8M | $49.8M | $36.3M | $9.3M | $7.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $420.9K | $628.8K | $57K | $37.7K | $31.3K | |
| Total Assets | $131.2M | $518.8M | $247.9M | $142.1M | $96.6M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $21.8M | $42M | $13M | $5.8M | $2.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $6.2M | $10.6M | $7.4M | $2.7M | $1.1M | |
| Other Current Liabilities | $1.1M | $3.5M | $872.1K | $56.4K | $31.7K | |
| Total Current Liabilities | $97.3M | $184.5M | $107.2M | $31M | $25.5M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $768.7M | $202.9M | $122.9M | $32.1M | $26.8M | |
| Common Stock | $7.8M | $47.9K | $51.9K | $49K | $48.4K | |
| Other Common Equity Adj | $12.6M | $7.6M | $2.9M | $9.1M | $10.9M | |
| Common Equity | -$645.2M | $315.9M | $125M | $110M | $69.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$637.4M | $315.9M | $125M | $110M | $69.7M | |
| Total Liabilities and Equity | $131.2M | $518.8M | $247.9M | $142.1M | $96.6M | |
| Cash and Short Terms | $93.5M | $433.9M | $185.3M | $105.4M | $67.2M | |
| Total Debt | $12.1M | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $119.3M | $219.8M | $119.4M | $59.1M | $40M | |
| Short Term Investments | -- | -- | -- | $10M | $8.5M | |
| Accounts Receivable, Net | -- | -- | $4.4M | $11.5M | $10M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $16.9M | -- | -- | -- | -- | |
| Other Current Assets | $331.5K | $23.8M | $16.9M | $18.3M | $13.8M | |
| Total Current Assets | $144.9M | $243.6M | $140.8M | $101.6M | $72.3M | |
| Property Plant And Equipment | $36M | $52.7M | $10M | $6.1M | $6.6M | |
| Long-Term Investments | -- | -- | -- | $685.6K | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $350K | $1.9M | $1.1M | $689.7K | $399.7K | |
| Total Assets | $183M | $298.2M | $151.9M | $109M | $79.2M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $29.9M | $59.9M | $21.5M | $18.7M | $14.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $6.6M | $13.6M | $2.7M | $1.3M | $1.1M | |
| Other Current Liabilities | $2.8M | -- | -- | -- | -- | |
| Total Current Liabilities | $143.5M | $156.9M | $29.9M | $25.6M | $20.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $155.6M | $176.4M | $31.6M | $26.8M | $21.9M | |
| Common Stock | $38.8K | $49.5K | $45.3K | $46.9K | $48.8K | |
| Other Common Equity Adj | $9.2M | $5.4M | $11M | $12.2M | $10.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $27.4M | $121.8M | $120.3M | $82.2M | $57.3M | |
| Total Liabilities and Equity | $183M | $298.2M | $151.9M | $109M | $79.2M | |
| Cash and Short Terms | $119.3M | $219.8M | $119.4M | $69.1M | $48.4M | |
| Total Debt | $2.6M | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$139.5M | -$194.2M | -$223.3M | -$26.5M | -$44.1M | |
| Depreciation & Amoritzation | $3.3M | $5.8M | $10M | $3.7M | $2.3M | |
| Stock-Based Compensation | $13.5M | $51.6M | $30.2M | $19.3M | $11.8M | |
| Change in Accounts Receivable | -- | -- | -- | -$5.4M | -$4.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$91.4M | -$75.8M | -$233.4M | -$69.1M | -$30M | |
| Capital Expenditures | $7M | $13M | $20M | $411.3K | $3.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.1M | -$13M | -$18.2M | -$1.3M | -$22.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $12.3M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$12.3M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$5.1M | -$7.3M | |
| Other Financing Activities | -- | -$2.7M | -$1.5M | -- | -- | |
| Cash From Financing | $12.2M | $405.4M | $147.5K | -$5M | -$7.3M | |
| Beginning Cash (CF) | $184.7M | $99.8M | $439.1M | $175.8M | $101.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$83.3M | $316.6M | -$251.4M | -$75.4M | -$60M | |
| Ending Cash (CF) | $99.7M | $410.8M | $182.9M | $106.9M | $43.4M | |
| Levered Free Cash Flow | -$98.4M | -$88.8M | -$253.4M | -$69.5M | -$33.7M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-23 | 2022-12-23 | 2023-12-23 | 2024-12-23 | 2025-12-23 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get YQ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
YQ
Sector
P/E ratio
--
16.87x
PEG ratio
-0.02x
0.22x
P/B ratio
0.22x
1.45x
Price / LTM sales
0.46x
0.71x
Growth Metrics
YQ
Sector
Revenue growth
33.63%
0.14%
Earnings growth
--
--
Revenue (5-year growth)
-12.46%
3.45%
Earnings forecast
--
$0.30
Profitability
YQ
Sector
Profitability FY 2023
$11.4M
$503.7M
Return on invested capital
-47.86%
5.17%
Return on assets
-35.02%
3.13%
Return on equity
-47.86%
7.63%
Earnings Date
Last Earnings Date
Dec
11
Next Earnings Date
Mar
20
Estimated Next Earnings Date
Mar
12
Balance Sheet
YQ
Sector
Total cash
$48.4M
$157.7M
Short term investments
$23.9M
$60.7M
Total assets
$96.6M
$1.7B
Long term debt
--
$111.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
